Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

By Molander Pauliina   af Björkesten Clas-Göran   Mustonen Harri   Haapamäki Johanna   Vauhkonen Matti   Kolho Kaija-Leena   Färkkilä Martti   Sipponen Taina  

Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. : 2011-2017

Blackwell Publishing

Access to resources Recommend Favorite

The Role of Genetics in Inflammatory Bowel Disease

By  

Current Drug Targets, Vol. 9, Iss. 5, 2008-05 ,pp. : 361-368

Bentham Science Publishers

Access to resources Recommend Favorite

Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs

By Sheffield Leslie J   Irving Peter   Gupta Arun   Byron Keith   Macrae Finlay A   Phillimore Hazel   Dronavalli Mithilesh   Rose Rosemary   George Peter   Walmsley Trevor   Dixon Barbara   Poole Susan   Dooley Michael   Sparrow Miles  

Pharmacogenomics, Vol. 10, Iss. 7, 2009-07 ,pp. : 1091-1099

Future Medicine

Access to resources Recommend Favorite

Role of probiotics in inflammatory bowel disease and intestinal infections

By Campieri M   Venturi A   Gionchetti P   Rizzello F   Amadini C   Palmonari V   Romagnoli R   Simone C De  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 8, 2001-08 ,pp. : 1277-1283

Informa Healthcare

Access to resources Recommend Favorite

Role of Rifaximin in Inflammatory Bowel Disease Treatment

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 3, 2016-02 ,pp. : 225-229

Bentham Science Publishers

Access to resources Recommend Favorite